- Different treatment approaches/intensities may be required depending on the severity of illness and individual preferences1
- Perinatal care providers should provide information about psychosocial and community-based supports (in person, virtual, or hybrid models) with patients presenting with perinatal mental health concerns1
- Most of the common pharmacological agents used to treat perinatal mood and anxiety disorders are not teratogenic1
- Pregnant and postpartum individuals will benefit from counselling focused on shared decision making1
General recommendations for treatment are outlined in the PMH Care Pathway Document.
For more information see CANMAT Clinical Practice Guidelines for the Management of Perinatal Mood, Anxiety and Related Disorders.
